I don't share the pumpers enthusiasm...sorry.I sold and am waiting to get back in, but so far I don't see any reason to.
I was into Sona, followed it closely, and see similarities here.
Thermas FEASIBILITY study produced 80% sensitivity. Sonas was higher than that with their lab results. When HC ran the necessary FIELD trials Sona failed. Field trials are "always" lower than lab trials because you don't have skilled scientists with a stake in the outcome, doing the tests in a perfect lab setting. Field trials are done in a real world situation by stressed out health care workers.
Field trials are always lower than lab trials and if Thermas are even 1% lower they FAIL.
Sure they may be able to improve things down the road somewhere but they are far behind and have a whopping 200 million shares outstanding! Thats ridiculous for a penny stock and make it very difficult to move the needle regardless of any news. To say this is worth 37 cents and is going to $7 is nothing but silly hype. You must remember that articles and publications get paid to write up your company. PAY them enough and they will say ANYTHING you want.
I am sure the pumpers will be all over me and heaven forbid, put me on ignore. jmho